Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
12 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
OHMX.bio from Evergem, company number BE0720593006, closed financial year 2025 with a result of € 1.2 million after tax. For that financial year OHMX.bio recorded a gross margin of € 1.7 million and equity of € 1.1 million. Compared with financial year 2024, the result moved from € -381,771 to € 1.2 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.
€ 1.1 million
▲ € 1.2 million vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 1.2 million
▲ still € 381,771 loss in 2024
Profit after tax over the fiscal year.
€ 3,552
▼ 81% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 645,592.
People and assets in 2025
5.9
▼ 1.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 447,321
▼ 19% vs 2024
€ 75,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 7,027
▼ 95% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 10,000
▼ 85% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 524,171 | € 326,697 | € 325,301 | € 1,746,626 | ▲ € 1.4 million |
| Profit after taxes | € -44,263 | € -156,148 | € -381,771 | € 1,228,397 | ▲ € 1.6 million |
| Equity | € 498,707 | € 246,656 | € -172,804 | € 1,055,592 | ▲ € 1.2 million |
| Total debts | € 519,983 | € 456,704 | € 585,106 | € 22,288 | ▼ 96% |
| Cash | € 194,437 | € 91,462 | € 18,771 | € 3,552 | ▼ 81% |
| Retained profit | € -44,885 | € -201,033 | € -582,804 | € 645,592 | ▲ € 1.2 million |
| Bank debt | € 351,284 | € 298,897 | € 370,332 | € 0 | ▼ 100% |
| Balance sheet total | € 1,018,691 | € 703,360 | € 412,302 | € 1,077,881 | ▲ 161% |
| Employees (FTE) | 5.7 | 6.4 | 7 | 5.9 | ▼ 1.1 |
Key figures of OHMX.bio, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to OHMX.bio?
What happened at OHMX.bio in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Quod Bonum Felix Faustumque Sit NV stepped down as director. NBB
- Post Verba Verbera NV stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 1.2 million. Source: NBB ↗
- Quod Bonum Felix Faustumque Sit NV became a director. NBB
- Post Verba Verbera NV became a director. NBB
- New establishment in Evergem. KBO
- Start of the company according to the CBE. KBO
In short
From € 44,263 loss in 2022 to € 1.2 million profit in 2025.
Paid € 356 in corporate taxes since 2022.
Best year ever: 2025, with € 1.2 million profit.
On average € 296,000 of value added per employee in 2025.
Management
The stake of POST VERBA VERBERA, Novalis comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
OHMX.bioThe shares are held by POST VERBA VERBERA (100%) and Novalis (83%).
Directors
According to the 2025 annual accounts
Quod Bonum Felix Faustumque Sit NV
Director · represented by Emiel Van Camp
Also active at: POST VERBA VERBERA
since 2024 · until 2029
Managing director · represented by Felix Van Camp
Also active at: LABORATORIUM M. NUYTINCK, LABO VOOR KLINISCHE BIOLOGIE, ANABIOTEC, Ziphius, MENTANA DX
since 2024 · until 2029
Shareholders
100%
83%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Noorwegenstraat 4
9940 Evergem
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 12 companies are registered at this address.
All companies at this address →LABORATORIUM M. NUYTINCK same network
€ 24.5 million revenue · 2025
LABO VOOR KLINISCHE BIOLOGIE same network
€ 3.6 million gross margin · 2025
POST VERBA VERBERA same network
€ 4.5 million revenue · 2025
ANABIOTEC same network
€ 9 million gross margin · 2025
Group Nuytinck
+7 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Certifications & Partners
Hosting & Email
Email provider
Google Workspace
Hosting
DSTNY-BACKBONE International Backbone, BE
Domain
Domain
ohmx.bio
Registered
2018-10-01
Registrar
Nomeo BV
Expires
2026-10-01
Website info
Features
Security
Details
- Company number
- 0720.593.006
- VAT number
- BE 0720.593.006
- Registered office
- Noorwegenstraat 4, 9940 Evergem
- Names & denominations
- OHMX.bio
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 12 February 2019
- Peppol
- Active · Active since 5 Dec 2025
- Contact
- ohmx.bio
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige technische testen en toetsen
Overige gespecialiseerde wetenschappelijke en technische activiteiten